Health ❯ Healthcare ❯ Regulatory Affairs

FDA Approval Process

Priority Review New Drug Application Clinical Trials Biologics License Application Drug Approval Timeline Drug Applications Marketing Applications Drug Studies Drug Approval for HIV Prevention Advisory Committees Vaccine Applications Clinical Trial Phases Drug Approval Applications Drug Approval Vaccine Review Process Prescription Medications Fast Track Designation Drug Efficacy Vaccine Approval Breakthrough Therapy Designation Drug Submissions Drug Development Clinical Trial Protocols Foundayo Approval National Health Priorities Clinical Trial Design Investigational Drugs Premarket Approval Drug Safety Galleri Test Approval Diagnostic Tests

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

The panel’s votes clear a major regulatory hurdle and send the application to the FDA for a final decision while regulators seek strict labeling and more outcome data.

FDA Advisory Panel Reviews GRAIL’s Galleri Multi‑Cancer Blood Test

Definium’s LSD-Based Therapy Posts Third Positive Phase 3 Result in GAD

AstraZeneca's Tozorakimab Cuts COPD Flare‑Ups in Two Phase 3 Trials

FDA Advisers Unanimously Back Moderna’s mRNA Flu Vaccine

Apnimed Pill Cuts Sleep Apnea Events in Phase 3 as Company Seeks FDA Approval

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Veradermics Advances Long-Acting Oral Minoxidil Into Phase 3 U.S. Trials

Cidara’s CD388 Antiviral Achieves Up to 76% Flu Protection in Phase 2b Trial